Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release while Breastfeeding
What is Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release ?
Brief: Expectorant
Is using Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release safe or dangerous while breastfeeding?
Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release Breastfeeding Analsys
Guaifenesin while Breastfeeding
Low RiskCAS Number: 93-14-1
It is used as an expectorant, alone or in association with other products. Proofs on its effectiveness are sparse. In some instances, preparations of Guaifenesin may contain alcohol as excipient with a concentration as high as 5%. At latest update, relevant published data on excretion into breast milk were not found. Until more information on this medication is available, other option known to be safer would be recommended, mostly in the post-natal period or in cases of prematurity. If used while breastfeeding, a moderate use with the lowest dose as possible and avoiding those preparations with alcoholic excipient, should be preferred. Because effectiveness is poor and likelihood of side effects does exist, especially in multi-association, the US Agency for Drug Administration (FDA) is currently doing efforts for discontinuation of this and others at-the-counter products, that are formulated for cough relief (Guaifenesin, Dextromethorphan, Phenylephrine, Pseudoephedrine, Brompheniramine, etc.)
Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release Breastfeeding Analsys - 2
Guaifenesin while Breastfeeding
CAS Number: 93-14-1
Neither the excretion of guaifenesin in milk nor its effect on breastfed infants have been studied. It is unlikely that with usual maternal doses amounts in breastmilk would harm the nursing infant, especially in infants over 2 months of age. It is best to avoid the use of products with a high alcohol content while nursing.
I already used Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release and meanwhile I breastfed my baby should I be concerned?
Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release is in the category of low risk, if you have already used it then its not a big deal if health and behavior of baby is good. However your health care provider shall be aware of the fact that you have used Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release so you should inform him based on your convenience.
My doctor has prescribed me Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release, what should I do?
Though Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.
If I am using Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release, will my baby need extra monitoring?
Not much monitoring required while using Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release
Who can I talk to if I have questions about usage of Guaifenesin Extended Release 600 Mg | Guaifenesin Tablet, Extended Release in breastfeeding?
US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week